KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $2.2 billion.

  • Gilead Sciences' Net Cash Flow fell 126.13% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 billion, marking a year-over-year increase of 41373.09%. This contributed to the annual value of $3.9 billion for FY2024, which is 54058.44% up from last year.
  • According to the latest figures from Q3 2025, Gilead Sciences' Net Cash Flow is $2.2 billion, which was down 126.13% from -$2.9 billion recorded in Q2 2025.
  • Gilead Sciences' Net Cash Flow's 5-year high stood at $5.0 billion during Q4 2024, with a 5-year trough of -$2.9 billion in Q2 2025.
  • Over the past 5 years, Gilead Sciences' median Net Cash Flow value was $32.0 million (recorded in 2022), while the average stood at $69.8 million.
  • Examining YoY changes over the last 5 years, Gilead Sciences' Net Cash Flow showed a top increase of 3161428.57% in 2024 and a maximum decrease of 35663.13% in 2024.
  • Quarter analysis of 5 years shows Gilead Sciences' Net Cash Flow stood at $985.0 million in 2021, then crashed by 35.23% to $638.0 million in 2022, then plummeted by 46.24% to $343.0 million in 2023, then surged by 1360.64% to $5.0 billion in 2024, then tumbled by 56.25% to $2.2 billion in 2025.
  • Its last three reported values are $2.2 billion in Q3 2025, -$2.9 billion for Q2 2025, and -$2.1 billion during Q1 2025.